Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | AMGN | VRTX | REGN | BMY |
| Company | Akari Therapeutics ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.6900 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 1.8676 | 278.52 | 404.07 | 943.77 | 44.42 |
| Low | 1.4800 | 274.90 | 398.46 | 891.30 | 43.33 |
| Last | 1.6300 | 277.92 | 401.06 | 936.01 | 43.84 |
| Change | -0.0700 | +0.55 | -1.08 | +32.53 | -0.37 |
| % Change | -4.12% | +0.20% | -0.27% | +3.60% | -0.84% |
| Volume | 27,617 | 1,293,380 | 562,436 | 655,109 | 9,380,081 |
| 20-Day Average Volume | 21,671 | 2,182,920 | 979,104 | 487,793 | 13,971,285 |
| Previous Close | 1.7000 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2786 | 270.12 | 398.74 | 909.16 | 47.83 |
| 20-Day Raw Stochastic | 55.69% | 84.24% | 51.06% | 83.59% | 5.65% |
| 20-Day Relative Strength | 47.72% | 52.23% | 46.72% | 54.16% | 27.69% |
| Weighted Alpha | -61.27 | +14.24 | +14.20 | +23.23 | -37.04 |
| Today's Opinion | 72% Sell | 24% Sell | 8% Buy | 48% Buy | 88% Sell |
| Previous Opinion | 72% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.89% since 04/25/24 | +2.76% since 04/25/24 | +0.75% since 04/25/24 | +5.27% since 04/25/24 | -2.00% since 04/25/24 |
| Low | 1.1700 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.8541 on 05/01/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 943.77 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | unch since 04/02/24 | +0.22% since 04/02/24 | -2.14% since 04/02/24 | -1.79% since 04/02/24 | -16.94% since 04/02/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.8541 on 05/01/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | -39.36% since 02/02/24 | -14.35% since 02/02/24 | -5.65% since 02/02/24 | -0.80% since 02/02/24 | -10.07% since 02/02/24 |
| Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.6352 on 02/06/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -57.34% since 11/02/23 | +3.84% since 11/02/23 | +6.41% since 11/02/23 | +14.51% since 11/02/23 | -14.33% since 11/02/23 |
| Low | 1.0775 on 04/17/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 3.6850 on 11/06/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,470 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 7,924 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -10,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -5,680,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.99 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |